Skip to content

Health-related Quality of Life in General Slovenian Population

Health-related Quality of Life in General Slovenian Poplation Assessed by the European Organisation for Research and Treatment of Cancer (EORTC) Core Quality-of-Life Questionnaire QLQ-C30

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01269489
Enrollment
600
Registered
2011-01-04
Start date
2010-12-31
Completion date
2012-09-30
Last updated
2012-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health-related Quality of Life

Keywords

quality of life, general Slovenian population, EORTC QLQ C30

Brief summary

The purpose of the study is to obtain reference data on health-related quality of life for the functional and symptom scales and single items of the European Organisation for Research and Treatment of Cancer Core Quality-of-Life Questionnaire (EORTC QLQ C30) in a representative sample of Slovenian general population.

Detailed description

A sample of at least 600 people from the Slovenian population, randomly selected, age 18 years and more, representing geografic diversity, will take part in this postal survey. The EORTC QLQ C30 and a questionnaire about demografic data will be send by mail. This is the first study to obtain reference data from the EORTC QLQ C30 in a sample from the general Slovenian population. The results will serve as guidelines for interpreting health-related quality-of-life of different groups of patients.

Interventions

None listed

Sponsors

Institute of Oncology Ljubljana
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* age 18 y and more

Exclusion criteria

* serious comorbidity * previously treated for cancer

Countries

Slovenia

Contacts

Primary ContactVaneja Velenik, PhD,MD
vvelenik@onko-i.si+38615879661
Backup ContactVesna Zadnik, PhD,MD
vzadnik@onko-i.si+38615879661

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026